2 min read
Press Releases
2 min read
AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
1 min read
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
2 min read
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
1 min read
AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site
2 min read
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
2 min read